Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check6 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2 as the page’s version label, indicating a minor backend/template update. It does not alter the study data, eligibility criteria, outcomes, or other user-visible content.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check43 days agoChange DetectedAdded related disease term familial multiple polyposis syndrome and an external resource link to the Genetic and Rare Diseases Information Center for additional context.SummaryDifference0.2%

- Check50 days agoChange DetectedRevision updated to v3.5.0, replacing the previous v3.4.3 revision.SummaryDifference0.1%

- Check65 days agoChange DetectedAdded revision: v3.4.3; removed revision: v3.4.2.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded a new revision note: Revision: v3.4.2; the funding-status notice and the previous revision (v3.4.1) were removed.SummaryDifference0.5%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.